NX-5948
NX-5948-201
Phase 2 small_molecule active
Quick answer
NX-5948 for Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) is a Phase 2 program (small_molecule) at Nurix Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Nurix Therapeutics
- Indication
- Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active